| scholarly article | Q13442814 |
| P2093 | author name string | Josef F Novak | |
| Mitchell I Chernin | |||
| Deborah A Heitzman | |||
| Kirsten L Elzer | |||
| P2860 | cites work | c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2 | Q24294848 |
| Thrombin receptor overexpression in malignant and physiological invasion processes | Q24323035 | ||
| The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells | Q24562218 | ||
| The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies | Q24671642 | ||
| Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells | Q28203283 | ||
| Mechanism of trypsin-induced contraction in the rat myometrium: the possible involvement of a novel member of protease-activated receptor | Q28345766 | ||
| The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection | Q28366344 | ||
| Chymotrypsin B cached in rat liver lysosomes and involved in apoptotic regulation through a mitochondrial pathway | Q28571338 | ||
| Activation of type IV procollagenases by human tumor-associated trypsin-2 | Q28619137 | ||
| Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells | Q29619848 | ||
| Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness | Q29620446 | ||
| Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. | Q30920864 | ||
| The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways | Q30989694 | ||
| No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer | Q34013819 | ||
| International Union of Pharmacology. XXVIII. Proteinase-activated receptors | Q34130822 | ||
| Proteolyzed matrix as a template for the regulation of tumor progression | Q34218154 | ||
| Protease activated receptors: theme and variations | Q34225983 | ||
| Tumors are unique organs defined by abnormal signaling and context | Q34231927 | ||
| Tumor invasion as dysregulated cell motility | Q34231938 | ||
| Protease-activated receptor-2 (PAR2) in the airways | Q34305483 | ||
| Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). | Q34332597 | ||
| Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. | Q34388721 | ||
| Endogenous inhibitors of angiogenesis. | Q34419511 | ||
| 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage | Q34686193 | ||
| Multiple pathways of cell invasion are regulated by multiple families of serine proteases. | Q34687536 | ||
| Protease-activated receptors: contribution to physiology and disease | Q35715253 | ||
| Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells | Q35749110 | ||
| Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles | Q36012122 | ||
| Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. | Q36028984 | ||
| Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength | Q36232820 | ||
| Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion | Q36420521 | ||
| Matrix metalloproteinases and cellular motility in development and disease. | Q36452765 | ||
| Expression cloning of oncogenes by retroviral transfer of cDNA libraries | Q36566564 | ||
| Role of thrombin receptor in breast cancer invasiveness | Q36618228 | ||
| Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype | Q36650343 | ||
| Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer | Q36753998 | ||
| Contact interactions between epitheliocytes and fibroblasts: formation of heterotypic cadherin-containing adhesion sites is accompanied by local cytoskeletal reorganization. | Q37108656 | ||
| Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells | Q39658447 | ||
| Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells | Q40333102 | ||
| PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 | ||
| Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. | Q40528868 | ||
| Thrombin enhances adhesion in pancreatic cancer in vitro through the activation of the thrombin receptor PAR 1. | Q40786271 | ||
| Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor | Q40947515 | ||
| Protease-mediated signalling: new paradigms for cell regulation and drug development | Q41098006 | ||
| Streptokinase inhibits pulmonary tumor seeding in an animal experimental model | Q41444122 | ||
| Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells | Q43263565 | ||
| Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin | Q43559301 | ||
| Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma | Q43740965 | ||
| Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice | Q44009214 | ||
| Distribution of integrin cell adhesion receptors in normal and malignant lung tissue | Q44429276 | ||
| The enzyme levels in blood are not affected by oral administration of a pancreatic enzyme preparation (Creon 10,000) in pancreas-insufficient pigs | Q44715484 | ||
| Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study | Q48683440 | ||
| Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. | Q50754008 | ||
| Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study. | Q51963544 | ||
| An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors. | Q53881002 | ||
| Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells | Q57942209 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 282-294 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Integrative Cancer Therapies | Q15708568 |
| P1476 | title | Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment | |
| P478 | volume | 7 |
| Q35531332 | Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth |
| Q37766499 | Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer |
| Q44959102 | Identifying differentially expressed genes in cancer patients using a non-parameter Ising model |
| Q93386603 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer |
| Q36156772 | Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer |
| Q34947713 | Trypsin potentiates human fibrocyte differentiation |
Search more.